BioAge Labs Inc. - BIOA Quarterly EPS earnings growth

BioAge Labs, Inc - graphic logo of issuer BIOA

The quarterly EPS growth trajectory demonstrates the potential of BioAge Labs, Inc. (BIOA) in the emerging obesity drug market. BioAge Labs, Inc. (BIOA) leverages AI-driven biobank analysis to compete with industry behemoths. Results depend on biological efficacy rather than economic cycles. Meanwhile, the -29.90 level serves as a critical benchmark, allowing for a real-time assessment of profit dynamics and investment risks.

BioAge (BIOA) - Year-over-year earnings per share growth for the last twelve months from 09/27/2024 to 11/15/2026

Financial and market metric breakdowns for BioAge Labs, Inc. (BIOA)

- share price and consensus valuation forecast:
Stock Quotes BioAge|BIOA - Analyst Forecast Prices
- issuer market value details:
Market Capitalization BioAge Labs, Inc|BIOA - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share BioAge Labs, Inc.|BIOA - Company Book Value|Market Value to Book Value Ratio bioagelabs.com|BIOA - Company Assets
- debt and liquidity data:
Debt to Equity BioAge Labs, Inc.|BIOA - Long-Term Debt to Equity|Short-Term Debt to Capital BioAge Labs|BIOA - Company Total Debt Obligations|Debt to Book Capitalization Ratio BioAge Labs|BIOA - Long-Term Debt Volume|Company Short-Term Debt BioAge Labs, Inc.|Quick Ratio bioagelabs.com
- earnings and valuation multiples indicators:
BIOA - Company Net Income|Projected Future Earnings BioAge Labs, Inc.|BIOA - Business Payback Period|Future Price to Earnings BioAge Labs|BIOA - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple BioAge Labs, Inc|BIOA - Operating profit EBITDA|Net earnings per share (EPS TTM) BioAge Labs, Inc.|BIOA - Net earnings per share for the trailing year|Quarterly EPS earnings growth bioagelabs.com|BIOA - Earnings per share growth rate in current year|Expected earnings per share growth for next year BioAge Labs, Inc.
- sales volume and revenue information:
BIOA - Company Sales Revenue|Company Projected Revenue BioAge Labs Inc.|BIOA - Price-to-Revenue Ratio|Forward P/S Multiple BioAge Labs, Inc
Analysis of all company metrics:BioAge Labs, Inc.
Manufactured product of BioAge Labs, Inc

This indicator captures the quarterly dynamics of earnings per share, reflecting the growth rates of business profitability. For BioAge Labs, Inc. (BIOA), this parameter will become critical during the monetization of premium anti-aging drugs. By analyzing the quarterly EPS growth trend, an investor can assess the speed of the company's pricing strategy implementation. A positive trajectory would confirm the issuer's pricing power. A steady increase in this metric will ensure a long-term inflow of capital.

Competitors of BioAge Labs, Inc. (BIOA)

ASND (Ascendis Pharma) - Year-over-year net earnings per share growth for the last 12 months|MDGL: Year-over-year earnings per share growth rate for the last twelve months|CORT (Corcept Therapeutics Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Rhythm Pharmaceuticals|Quarterly EPS earnings growth AKRO|Year-over-year earnings per share growth for the last twelve months MTSR (Metsera, Inc.)|Year-over-year earnings per share growth for the last twelve months moonlaketx.com MLTX|Crinetics Corp (CRNX) - Earnings per share growth in annualized terms for the last twelve months|NAMS - Year-over-year earnings per share growth for the last twelve months|SLNO: Year-over-year earnings per share growth for the last twelve months|FOLD: Quarterly EPS earnings growth|ETNB - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Agios Corp|Structure Corp (GPCR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months mimedx.com (MDXG)|Year-over-year net earnings per share growth for the last 12 months rezolutebio.com RZLT|Year-over-year earnings per share growth for the last twelve months Lexicon Pharmaceuticals, Inc. LXRX|MBX Bio - Year-over-year earnings per share growth for the last twelve months|ALT: Year-over-year net earnings per share growth for the last 12 months|AARD - Quarterly EPS earnings growth|SGMT: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months biomeafusion.com (BMEA)|Year-over-year earnings per share growth for the last twelve months Quince Therapeutics, Inc.|Year-over-year net earnings per share growth for the last 12 months Fractyl (GUTS)|Year-over-year net earnings per share growth for the last 12 months VTVT (vTv Therapeutics Inc.)|ATPC - Earnings per share growth in annualized terms for the last twelve months|Pluri Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Synlogic Corp|LPCN - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Matinas BioPharma Holdings, Inc. MTNB|SPRB: Quarterly EPS earnings growth|Galecto Corp - Year-over-year earnings per one share growth for the last 12 months|CTCX (carmellrx.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth lumos-pharma.com|Quarterly EPS earnings growth ONVO|Year-over-year net earnings per share growth for the last 12 months Radius Health RDUS